Management and treatment outcomes of rheumatoid arthritis in the era of biologic and targeted synthetic therapies: evaluation of 10-year data from the KURAMA cohort | Synapse
January 9, 2024Open Access
Management and treatment outcomes of rheumatoid arthritis in the era of biologic and targeted synthetic therapies: evaluation of 10-year data from the KURAMA cohort
Key Points
Key points are not available for this paper at this time.
Abstract
With the development of new RA therapeutics, overall treatment outcomes advanced in the past decade.